HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gebhardt, M. C. Search for Related Content PubMed PubMed Citation Articles by Gebhardt, M. C.

Perspectives on Health Disparities in Orthopaedic Oncology

Dr. Gebhardt is Frederick W. and Jane M. Ilfeld Professor of Orthopaedic Surgery, Harvard Medical School, and Orthopaedic Surgeon-in-Chief, Beth Israel Deaconess Medical Center, Boston, MA.

Neither Dr. Gebhardt nor the department with which he is affiliated has received anything of value from or owns stock in a commercial company or institution related directly or indirectly to the subject of this article.

A few studies indicate that race- and culture-related differences exist among patients with bone tumors. However, there is little information regarding sarcomas. Existing studies indicate that, in the United States, race and cultural background may not significantly affect the survival rate of patients with sarcoma. As we learn more, however, orthopaedic oncologists should look to areas of oncology in which race-based disparity has been reported—specifically, among patients with prostate or breast cancer. These patient populations have been more widely studied, and physicians have pinpointed measures to reduce or eliminate gaps in patient care and prognosis. In particular, oncologists have called for culture-specific patient education. Further research is required to identify disparities, if any, and to ensure equitable patient prognoses.